Sa**fi may win U.S. approval of $3 billion eczema drug by March
 

Sa**fi may win U.S. approval of $3 billion eczema drug by March
(Reuters) - French drugmaker Sa**fi *and its U.S. partner Regeneron Pharmaceuticals could win U.S. approval for their keenly awaited new eczema drug dupilumab, seen by analysts as a potential $3 billion-a-year seller, by next March.http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...KU:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...KU:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/9vZCybgV7VY